OUR PORTFOLIO

Our portfolio includes grants and mission-related investments supporting Alzheimer’s drugs in development, biomarkers, prevention programs, and other projects designed to build the capacity of the field. You can explore the programs we have supported using the filter and “Search Database” options in the sidebar.

All Filters

To reveal more filter options, please select whether you would like to review Active or Closed projects:

Clear
Investigator: Roberta Diaz Brinton

6 Projects | 1 Researchers | $1,213,447 Invested

2017

University of Arizona

Roberta Diaz Brinton, PhD

2017 Annual Goodes Prize for Excellence in Alzheimer's Drug Discovery: Allopregnanolone Novel Patentable Formulation to Advance Commercialization

  • Funding Amount: $150,000
  • Organization Type: Academic/Nonprofit
  • Program: Clinical
  • Target: Neuronal Regeneration and Repair
  • Status: Closed

2016

University of Arizona

Roberta Diaz Brinton, PhD

Manufacturing of Allopregnanolone for Phase 2 Clinical Trial

  • Funding Amount: $450,000
  • Organization Type: Academic/Nonprofit
  • Program: Clinical
  • Target: Neuronal Regeneration and Repair
  • Status: Closed

2015

University of Southern California

Roberta Diaz Brinton, PhD

Allopregnanolone Phase 1 to Phase 2 Acceleration Project

  • Funding Amount: $338,788
  • Organization Type: Academic/Nonprofit
  • Program: Clinical
  • Target: Neuronal Regeneration and Repair
  • Status: Closed

2007

University of Southern California

Roberta Diaz Brinton, PhD

Allopregnanolone as a Neurogenic Factor for Recovery of Neurons in Alzheimer's Disease

  • Funding Amount: $56,998
  • Organization Type: Academic/Nonprofit
  • Program: Drug Discovery
  • Target: Neuronal Regeneration and Repair
  • Status: Closed

2006

University of Southern California

Roberta Diaz Brinton, PhD

Allopregnanolone as a Neurogenic Factor for Recovery of Neurons in Alzheimer's Disease

  • Funding Amount: $95,000
  • Organization Type: Academic/Nonprofit
  • Program: Drug Discovery
  • Target: Neuronal Regeneration and Repair
  • Status: Closed

2004

University of Southern California

Roberta Diaz Brinton, PhD

Allopregnanolone as a Neurogenic Factor for Recovery of Neurons in Alzheimer's Disease

  • Funding Amount: $122,661
  • Organization Type: Academic/Nonprofit
  • Program: Drug Discovery
  • Target: Neuronal Regeneration and Repair
  • Status: Closed